Benjamin Edwards Inc’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
57,760
+6,845
| +13% | +$333K | 0.04% | 392 |
|
|
2025
Q1 | $1.73M | Buy |
50,915
+5,853
| +13% | +$199K | 0.02% | 448 |
|
|
2024
Q4 | $1.77M | Buy |
45,062
+12,359
| +38% | +$486K | 0.03% | 466 |
|
|
2024
Q3 | $1.54M | Buy |
32,703
+32,465
| +13,641% | +$1.53M | 0.02% | 485 |
|
|
2024
Q2 | $13K | Sell |
238
-131
| -36% | -$7.16K | ﹤0.01% | 611 |
|
|
2024
Q1 | $25K | Buy |
369
+30
| +9% | +$2.03K | 0.01% | 552 |
|
|
2023
Q4 | $21K | Sell |
339
-165
| -33% | -$10.2K | ﹤0.01% | 535 |
|
|
2023
Q3 | $23K | Buy |
504
+13
| +3% | +$593 | 0.01% | 525 |
|
|
2023
Q2 | $28K | Sell |
491
-67
| -12% | -$3.82K | 0.01% | 513 |
|
|
2023
Q1 | $25K | Buy |
558
+30
| +6% | +$1.34K | 0.01% | 520 |
|
|
2022
Q4 | $21K | Buy |
528
+107
| +25% | +$4.26K | 0.01% | 503 |
|
|
2022
Q3 | $28K | Sell |
421
-78
| -16% | -$5.19K | 0.01% | 473 |
|
|
2022
Q2 | $30K | Buy |
499
+19
| +4% | +$1.14K | 0.01% | 476 |
|
|
2022
Q1 | $30K | Buy |
480
+10
| +2% | +$625 | 0.01% | 510 |
|
|
2021
Q4 | $36K | Buy |
470
+74
| +19% | +$5.67K | 0.01% | 453 |
|
|
2021
Q3 | $44K | Sell |
396
-14
| -3% | -$1.56K | 0.03% | 319 |
|
|
2021
Q2 | $66K | Sell |
410
-68
| -14% | -$10.9K | 0.05% | 249 |
|
|
2021
Q1 | $58K | Sell |
478
-67
| -12% | -$8.13K | 0.04% | 242 |
|
|
2020
Q4 | $83K | Sell |
545
-233
| -30% | -$35.5K | 0.06% | 203 |
|
|
2020
Q3 | $65K | Buy |
778
+48
| +7% | +$4.01K | 0.05% | 197 |
|
|
2020
Q2 | $54K | Hold |
730
| – | – | 0.05% | 194 |
|
|
2020
Q1 | $31K | Buy |
730
+109
| +18% | +$4.63K | 0.03% | 208 |
|
|
2019
Q4 | $38K | Buy |
621
+54
| +10% | +$3.3K | 0.08% | 139 |
|
|
2019
Q3 | $23K | Buy |
567
+21
| +4% | +$852 | 0.05% | 158 |
|
|
2019
Q2 | $26K | Buy |
546
+268
| +96% | +$12.8K | 0.06% | 149 |
|
|
2019
Q1 | $10K | Buy |
+278
| New | +$10K | 0.05% | 202 |
|